Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07345260 · ClinicalTrials.gov registry record · NA

The Effects of a Nutritional Supplement on Sleep Quality

A NA study of Sleep and Sleep Quality, sponsored by Athletic Greens International.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT07345260: Recruiting NA study of Sleep and Sleep Quality, sponsored by Athletic Greens International.

NCT07345260 is a NA study of Sleep and Sleep Quality that is actively recruiting participants, run by Athletic Greens International. The registered enrollment target is 140 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07345260, a NA study of Sleep and Sleep Quality, is actively recruiting participants, sponsored by Athletic Greens International.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, double-blind, placebo-controlled study of N=140 adult men and women with sub-clinical sleep issues. This study to assess the effect of a novel dietary supplement on sleep related outcomes.

Primary Outcome

Assessed via Oura ring

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Novel powdered sleep supplement

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2026-01-02
Est. Completion 2026-05-30
Phase NA
Athletic Greens International

8 total trials

What NCT07345260 shows while recruiting

NCT07345260 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07345260 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07345260 about?

NCT07345260 is a clinical study titled "The Effects of a Nutritional Supplement on Sleep Quality". This study is a randomized, double-blind, placebo-controlled study of N=140 adult men and women with sub-clinical sleep issues. This study to assess the effect of a novel dietary supplement on sleep related outcomes.

What is the current status of trial NCT07345260?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2026-01-02. Estimated completion is 2026-05-30.

What conditions does trial NCT07345260 study?

This clinical trial studies the following conditions: Sleep, Sleep Quality.

What interventions are being tested in trial NCT07345260?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Novel powdered sleep supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07345260?

This trial is sponsored by Athletic Greens International, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07345260 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07345260's enrollment target sits among peer trials

140 43rd of 151 higher than 108 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07345260, the US trial registry maintained by the National Library of Medicine. NCT07345260 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.